These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 18211650)

  • 1. Our genes are not our destiny: incorporating molecular medicine into clinical practice.
    Genuis SJ
    J Eval Clin Pract; 2008 Feb; 14(1):94-102. PubMed ID: 18211650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular medicine: how, what, and when?
    Woodcock J
    Clin Pharmacol Ther; 2007 Oct; 82(4):376-8. PubMed ID: 17851578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrating molecular medicine into the US health-care system: opportunities, barriers, and policy challenges.
    Deverka PA; Doksum T; Carlson RJ
    Clin Pharmacol Ther; 2007 Oct; 82(4):427-34. PubMed ID: 17687271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical practice and community health care in the 21st century: a time of change.
    Genuis SJ
    Public Health; 2008 Jul; 122(7):671-80. PubMed ID: 18534645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the continuum: medical information to effective clinical practice. Paper II. Towards aetiology-centred clinical practice.
    Genuis SJ; Genuis SK
    J Eval Clin Pract; 2006 Feb; 12(1):63-75. PubMed ID: 16422781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Personalized medicine: elusive dream or imminent reality?
    Lesko LJ
    Clin Pharmacol Ther; 2007 Jun; 81(6):807-16. PubMed ID: 17505496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management, part I: introduction and general considerations.
    Manchikanti L
    Pain Physician; 2008; 11(2):161-86. PubMed ID: 18354710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of molecular medicine on pathophysiology, medical practice, and medical education.
    Gamulin S
    Croat Med J; 2003 Aug; 44(4):374-85. PubMed ID: 12950140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A revolution in genetics: changing medicine, changing lives.
    Bottles K
    Physician Exec; 2001; 27(2):58-63. PubMed ID: 11291222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating the value of genomic diagnostics: implications for clinical practice and public policy.
    Issa AM
    Adv Health Econ Health Serv Res; 2008; 19():191-206. PubMed ID: 19548519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic testing considerations for oral medicine.
    Hart TC; Ferrell RE
    J Dent Educ; 2002 Oct; 66(10):1185-202. PubMed ID: 12449214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Translating genomic biomarkers into clinically useful diagnostics.
    Ginsburg GS; Haga SB
    Expert Rev Mol Diagn; 2006 Mar; 6(2):179-91. PubMed ID: 16512778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenetics in clinical practice: considerations for testing.
    Constable S; Johnson MR; Pirmohamed M
    Expert Rev Mol Diagn; 2006 Mar; 6(2):193-205. PubMed ID: 16512779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The social construction of chronicity--a key to understanding chronic care transformations.
    Martin CM; Peterson C
    J Eval Clin Pract; 2009 Jun; 15(3):578-85. PubMed ID: 19522914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence-based medicine beyond the bedside: keeping an eye on context.
    Tilburt JC
    J Eval Clin Pract; 2008 Oct; 14(5):721-5. PubMed ID: 19018902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical doctors profile in Ethiopia: production, attrition and retention. In memory of 100-years Ethiopian modern medicine & the new Ethiopian millennium.
    Berhan Y
    Ethiop Med J; 2008 Jan; 46 Suppl 1():1-77. PubMed ID: 18709707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.